SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY), a leading provider of medical devices for the newborn care, hearing, and neurology markets, today announced that it completed a public offering of 4,600,000 shares of its common stock at a price of $19.50 per share, including 600,000 shares sold as a result of the underwriters’ exercise of their over-allotment option in full. Natus will receive net proceeds from the offering, including the sale of the over-allotment shares, of approximately $84,300,000 before expenses. At the completion of the offering Natus had approximately 27,566,000 shares issued and outstanding.
